EMA Medicine safety communications
Senvelgo: adverse event
Published by European Medicines Agency: · Ref. EMEA/V/C/005972
Summary
Adverse event
Medicine
Senvelgo
- Category
- Medicine safety communications
- Product type
- Veterinary medicine
- Active substance(s): velagliflozin L-proline monohydrate
- Species: Cats
Source: EMA — medicine safety communications — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗